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Abstract
Background: Many malaria-related studies depend on infected red blood cells (iRBCs) as fundamental material;
however, infected blood samples from human or animal models include leukocytes (white blood cells or WBCs),
especially difficult to separate from iRBCs in cases involving Plasmodium vivax. These host WBCs are a source of
contamination in biology, immunology and molecular biology studies, requiring their removal. Non-woven fabric
(NWF) has the ability to adsorb leukocytes and is already used as filtration material to deplete WBCs for blood
transfusion and surgery. The present study describes the development and evaluation of a prototype NWF filter
designed for purifying iRBCs from malaria-infected blood.
Methods: Blood samples of P. vivax patients were processed separately by NWF filter and CF11 column methods.
WBCs and RBCs were counted, parasite density, morphology and developing stage was checked by microscopy,
and compared before and after treatment. The viability of filtrated P. vivax parasites was examined by in vitro short-
term cultivation.
Results: A total of 15 P. vivax-infected blood samples were treated by both NWF filter and CF11 methods. The
WBC removal rate of the NWF filter method was 99.03%, significantly higher than the CF11 methods (98.41%, P <
0.01). The RBC recovery rate of the NWF filter method was 95.48%, also significantly higher than the CF11 method
(87.05%, P < 0.01). Fourteen in vitro short-term culture results showed that after filter treatment, P. vivax parasite
could develop as normal as CF11 method, and no obvious density, developing stage difference were fund
between two methods.
Conclusions: NWF filter filtration removed most leukocytes from malaria-infected blood, and the recovery rate of
RBCs was higher than with CF11 column method. Filtrated P. vivax parasites were morphologically normal, viable,
and suitable for short-term in vitro culture. NWF filter filtration is simple, fast and robust, and is ideal for purification
of malaria-infected blood.
Background
Malaria is a mosquito borne parasitic disease that causes
about 1 million fatalities a year, most occurring in
Africa. According to a WHO estimate, 3.3 billion people
are at risk of malaria [1]. Because no effective vaccine
currently exists, all humans are potentially susceptible to
malaria. Better control and eradication of malaria
requires more thorough research on the biological char-
acteristics of the parasite.
The establishment of continuous cultures of Plasmo-
dium falciparum provided researchers with abundant
materials that led to several breakthroughs [2]. Com-
pared to P. falciparum, research on Plasmodium vivax
is less extensive, not only because vivax malaria is rela-
tive mild and therefore neglected, but also because of
the biological properties of P. vivax[3]. First, in vitro
cultivation of P. vivax is not well established, and lim-
ited to short-term maintenance. Usually, parasite density
of P. vivax during culture does not obviously increase as
it does with P. falciparum, but decreases [4]. Second,
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primates, which are difficult to obtain. The biological
properties of in vivo propagated parasites are not exactly
the same as parasites isolated from naturally infected
humans, so they cannot represent the entire set of char-
acteristics of P. vivax in nature. Rodent malaria parasites
are easy to propagate in vivo, and parasitaemia can be
high, making it a realistic animal model for some
malaria researches [5]. However, blood from infected
human or animal models includes leukocytes, and espe-
cially in cases of P. vivax cases, the amount of WBCs is
often equal to or greater than iRBCs. These host source
WBCs have high metabolism capacity, are a contamina-
tion in malaria biology, immunology and molecular biol-
ogy studies, and need to be removed [6].
Currently, the methods for removing WBCs from
malaria-infected blood include CF11 column and Plas-
modipur filter filtration [7-13]. CF11 cellulose column is
the most commonly used method, it is cheap but time
consuming and laborious, and Plasmodipur filter is
expensive for resource-limited settings, therefore a new
method is required for purification of malaria-infected
blood. Leukocytes can be depleted by filtering through
non-woven fabric filters [14], because this type of blood
cells had strong adhesion function based on its cell sur-
face properties. This is in contrast to RBCs, which are
capable of deformation, and can escape from the rigid
fibers [15]. Even though the surface of iRBCs is altered
by parasite protein trafficking to the host cell mem-
branes, iRBCs still flow through the filter material, allow-
ing iRBCs to be purified from WBC contaminants. The
present study describes the development and evaluation
of a prototype NWF filter designed for purifying iRBCs
from malaria-infected blood.
Methods
The development of prototype NWF filter
The PBT (polybutylene terephthalate) melt-blown non-
woven fabric modified with polar groups(Gaolite medical
equipment Ltd., Zhangjiagang, China) was used as the fil-
ter media, and the shape of NWF filter was referred to
single-use sterilizing filter. Injection molding machine
(MA1200/370, Haitian, Ningbo, China) and ultrasonic
plastic welder (EM20-2, Branson, Shanghai, China) were
used to produce and assemble the polycarbonate shells
with NWF filter pad.
There are four major criteria of new filter for purifica-
tion of malaria-infected blood: a) One single-use filter is
capable for treatment of 5 ml P. vivax-infected blood; b)
For 5 ml whole blood, the WBC removal rate should be
>99%; c) After filtration, malaria parasite keeps viable,
and is suitable for in vitro short-term culture; d) It is also
suitable for treatment of rodent malaria-infected blood.
Plasmodium vivax-infected sample collection and
processing
Plasmodium vivax-infected blood samples were collected
in the north part of Anhui province from July 2007 to
September 2010. Only P. vivax was prevalent in this area
[16]. All malaria cases were confirmed by microscopy.
After consent was obtained from adult patients, 10-15 ml
of whole blood was drawn into heparin-treated vacuum
tubes, and mixed. Blood samples were sealed and
immersed in 37°C water in a thermos flask and immedi-
ately transferred to the laboratory in the Parasitology
Department of Bengbu Medical College. Thick- and thin-
smear were made, stained with Giemsa (Fisher, USA),
and examined by microscopy. After mixing and transfer-
ring whole blood into a 50 ml centrifuge tube, and spin-
ning for 5 min at 2,000 rpm, plasma was removed. To
compare efficiency of leukocyte removal, incomplete
RPMI 1640 medium (Invitrogen, USA) was used to resus-
pend the cell pellet to 30 ml. A 200 μl cell suspension
was transferred to a centrifuge tube, for counting WBCs
and RBCs using the improved Neubauer chamber
method. A 20 ml cell suspension was separated in two 50
ml centrifuge tubes, each containing the equivalent of
about 5 ml of whole blood.
Purification of P. vivax-infected blood sample by the NWF
filter method
T e nm lo fc e l ls u s p e n s i o np r e p a r e da b o v ew a ss u c k e d
into a 20 ml syringe, the filter inlet interface was adapted
to the syringe, and the plunger was gently pushed (about
5 ml/min). Then collect flow-through cell suspension
from the filter outlet into a new 50 ml centrifuge tube.
The filter was washed with 5 ml RPMI 1640, and eluted
cell suspension collected in the same tube. The sample
was spun 10 min at 3,000 rpm, the supernatant dis-
carded, and RPMI 1640 used to resuspend the pellet to
10 ml, and WBCs and RBCs were counted as described
above. A 10 μl cell suspension was used to make thick-
and thin- smears for staining and examination as above.
Purification of P. vivax-infected blood sample by CF11
column method
CF11 powder was purchased from Whatman (Maid-
stone, UK), and CF11 columns were prepared as
described previously [7]. The CF11 powder bed was
packed in a central luer syringe column with a sterile
foil package by tapping on the bench, and a pre-rinsed
CF11 bed was made by dropping in 5 ml RPMI 1640.
Before the last portion of liquid ran into the bed, 10 ml
of cell suspension was applied to the bed dropwise, and
then the bed was rinsed with 5 ml RPMI 1640. The cell
suspension was eluted into a 50 ml centrifuge tube.
Sample washing, counting of WBCs and RBCs, slide
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were compared to NWF filter method.
In vitro short-term culture of filtrated P. vivax samples
Both NWF filter and CF11 column treated RBC samples
from P. vivax patients with more than 50% ring stage
parasites and without prior anti-malarial therapy were
washed three times with RPMI 1640, and resuspended
at 2% haematocrit in McCoy’s 5A medium (Sigma-
Aldrich) containing 20% human AB+ serum (prepared
from malaria-naive donors)[17] and added into 10 wells
of a 96-well plate, each well contains 100 μl of cell sus-
pension. The test plate was incubated at 37°C, 5% CO2,
humidified environment for 48 h. A thick- and thin-
smear was made to check the development status of
P. vivax parasites for every 8 hours. The parasitaemia
and morphology of parasite of each slide were checked
by microscopy.
Purification of P. berghei-infected mouse blood samples
Heparin-treated Plasmodium berghei-infected mouse
blood samples were provided by the Parasitology Depart-
ment of Bengbu Medical College. Plasma of each sample
was removed by centrifugation, and packed cells were
diluted in RPMI 1640 to 5 ml, then filtered through NWF
filter and washed as previously for P. vivax samples. Sam-
pling and counting for WBCs were carried out as above.
Thick- and thin-smears were made and Giemsa stained
pre- and post filtration for observation.
Purification of P. falciparum sample in vitro
A0 . 5m lo fin vitro-cultured P. falciparum (FCC1/HN
isolate) sample at 5% parasitaemia was mixed with fresh
prepared 4.5 ml of healthy volunteer’s plasma-free
blood, and then filtered through NWF filter as described
above. Thick- and thin- smears were made and Giemsa
stained to observe the change of WBCs and infected
RBCs pre- and post filtration.
Statistical analysis
All data were entered and analysed using SPSS for
Windows v14 (SPSS Inc., Chicago, IL). The Wilcoxon
two-sample paired signed rank test was used to com-
pare the differences in WBC removal, RBC recovery
and parasite density between NWF filter and CF11
column methods. Statistical significance was set at P ≤
0.05.
Ethical considerations
The study was approved by the Institutional Review
Board (IRB00004221) of Jiangsu Institute of Parasitic
Diseases, Wuxi, China.
Questionnaire surveys, physical examination and
laboratory work were conducted after the purpose of
the study had been explained to participants, who were
given the right to withdraw from the study at any time,
without consequences. Written informed consent was
obtained from each participant.
Results
Development of NWF filter for purification of malaria-
infected blood
Upper and lower parts of polycarbonate shells of new
NWF filter were produced by plastic injection molding.
It has three layers of non-woven fabric unit in 2.2 cm
diameter as filter pad, and ultrasonic welding method
was adopted for assembling the upper part, filter pad
and lower part into a prototype NWF filter (Figure 1).
Filters were washed by distilled water and sterilized with
ethylene oxide gas, and stored in GMP environment for
one month before use.
Comparison of NWF filter filtration and CF11 column
methods for purification of P. vivax-infected blood
At o t a lo f1 5P. vivax-infected blood samples were used
for both NWF filtration and CF11 methods. WBCs and
RBCs were counted before and after treatment, and the
removal rate of WBCs and the recovery rate of RBCs
were calculated, and the parasite density was counted by
microscopy (Additional file 1). The average WBC
removal rate by the NWF filter was 99.03%, and the RBC
recovery rate was 95.48%. The average WBC removal
rate of the CF11 method was 98.41%, and the RBC recov-
ery rate was 87.05%. Significance differences were
observed between the two methods for WBC removal
(P < 0.01), and a clear significant difference between the
two methods was seen for RBC recovery (P <0 . 0 1 ) .T h e
NWF filter method was better than the CF11 column
method, especially for high performance RBC recovery.
Post-filtration, there is no parasite density difference
between NWF filter and CF11column methods (P > 0.05)
by microscopy, but the WBCs were substantially reduced
(Figure 2).
In vitro short-term culture of P. vivax after filtration
A total of 14 P. vivax-infected blood samples were treated
by both NWF filter filtration and CF11 column methods,
and subjected to in vitro short-term culture. Compared
to CF11 column method, parasites filtrated by NWF filter
are of same ability to continue developing into mature
stage in vitro, and there are no obvious changes been
observed in parasite density, morphology or stage pro-
portion between two methods by microscopy (Figure 3).
Purification of P. berghei-infected sample
Five P. berghei-infected mouse blood samples were
diluted and filtrated by NWF filter method, the WBC
removal rate was 99.21%. By microscopy comparison of
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parasite density, morphology or stage proportion
changes of P. berghei been observed (Figure 4).
Purification of P. falciparum in vitro
When the WBCs were removed from the sample mixed
with in vitro cultured P. falciparum-infected RBCs and
healthy donor blood, there were no obvious changes in
parasite density, morphology or stage proportion of P.
falciparum observed between pre- and post-filter
filtration.
Discussion
The prototype NWF filter developed here was designed
to remove >99% of leukocytes from 5 ml of whole
blood, with a 95% RBC recovery rate. After testing with
15 P. vivax-infected blood samples, the rates of WBC
removal and RBC recovery for the NWF filter method
were 99.03% and 95.48%, and for the CF11 method they
were 98.41% and 87.05%. NWF filter showed both
higher WBC removal and RBC recovery rates over CF11
column method. To save time in sample processing,
only one wash step was used, which may have contribu-
ted to the difference in RBC recovery between the two
methods.
In some studies, the purity and viability of parasites in
malaria samples are crucial for results, and a convenient
method for removal of contaminating WBCs is needed. In
this study, processing 5 ml of whole blood using the CF11
method requires at least 30 minutes from pre-rinsing the
column bed to the final drop of the cell suspension flow-
through. In contrast, the NWF filter method saves time
and is easy to perform. Filtration of same amount blood is
possible in 5 minutes from diluting sample to the end of
the wash procedure. Furthermore, the filtration method is
more robust than the CF11 method; the latter method
may fail if the column was not prepared properly, resulted
in an unacceptable amount of WBCs leakage. NWF filters
could be sealed in plastic bag and batch sterilized thus
could be ready to use, with no need to prepare or auto-
clave before use, as is required for CF11 columns. Training
for using NWF filter is minimal, and researchers can suc-
cessfully perform filtration by following the protocol. Filter
filtration does not need additional equipment, so it is sui-
table for use in field settings.
According to malaria genome and transcriptome stu-
dies, contamination from the host is the difficult pro-
blem in research, lowering the credibility of sequencing
and annotation results [18]. For example, about 10% of
host sequences are incorrectly in the Plasmodium yoelii
genome results [19]. By NWF filtration, more than 99%
leukocytes were removed from malaria-infected blood,
providing purified materials for downstream malaria
research, it suggest that NWF filter could be useful for
sample pretreatment in malaria molecular studies.
In recent years, reports on the chloroquine resistance
of P. vivax have gradually increased, and in vitro tests
were considered as direct and more important evidence
Figure 1 Prototype NWF filter for purification of malaria-infected blood. The prototype single-use NWF filter is designed for removing 99%
leukocytes from 5 ml malaria-infected blood sample at 95% RBC recovery rate: (A) Diagram of the prototype filter, (B) The shape of NWF filter,
(C~D) Scanning electron micrographs of PBT melt-blown non-woven fabric material.
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vivax not only disturbs the development of parasites and
interferes with microscopy, more importantly, makes
drug accumulated and decreases the concentration of
drugs, and so IC50 results may be falsely achieved [21].
Thus, removal of WBCs from P. vivax-infected blood
samples is a necessary procedure for in vitro drug sus-
ceptibility tests. In this study, P. vivax parasites filtered
Figure 2 Leukocyte removal efficacy of NWF filter filtration coupled with 60% Percoll concentration.AP. vivax blood sample was treated
by NWF filter filtration then performed 60% Percoll concentration: (A) Excessive WBC contamination in the 60% Percoll enrichment slide without
removing WBC (100× oil-immersion objective), (B) With NWF filter filtration, no WBCs could be observed. (100× oil-immersion objective), (C) Even
including more RBCs, still no single WBC was fund (40× high power objective), the rectangle represent the same field of (B).
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vitro, and with no obvious changes in density, morphol-
ogy and stage proportion compared to CF11 method.
Escaped WBCs and platelets may cast negative impact
on P. vivax during in vitro culture, and post NWF filter
treatment, the major component of escaped WBCs were
lymphocytes, and most of platelets were removed, these
properties were similar to CF11 method [7]. The devel-
opment of NWF filter provides researchers a useful tool
for further in vitro antimalarial drug sensitivity
surveillance.
Using rodent models to investigate malaria has
obvious advantages including easy for maintaining, cost
efficient and avoiding risks associated with human mate-
rial. In this study, results showed NWF filter are suitable
for purification of P. berghei-infected mouse blood,
among high WBC removal ability, more importantly, the
filter method enables a higher RBC recovery rate than
the CF11 method, making it more convenient for treat-
ment of small amount samples. Even in vitro cultivation
could provide purified P. falciparum parasites, though
the parasites isolated from patient blood still play
unique role in many studies. The new NWF filter could
be used for purification of P. falciparum samples too. In
this study, including mature stage P. falciparum-infected
RBC could pass through the non-woven fabric filter
material, this result is different from the report of using
routine transfusion filter to deplete P. falciparum-
infected RBC [22], this may be caused by the difference
of filtration materials, sample size and iRBC load.
Figure 3 In vitro short-term culture of P. vivax after NWF filter filtration. CF11 column method panel (A~F) and NWF filter method panel
(J~N). A, J: Rings; B, I: early trophozoite; C, K: late trophozoite; D, L: Young schizont; E, M: mature schizont; F, N: gametocyte.
Figure 4 NWF filter filtration for purification of Plasmodium berghei. (A) Before filtration, a great many WBCs were observed (40× high
power objective), (B) After filtration, no WBC were observe d (40× high power objective).
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NWF filter filtration removed most leukocytes from
malaria-infected blood, and the recovery rate of RBCs was
higher than with CF11 column method. Filtration could
enable more efficient use of malaria samples for research.
No obvious parasite density decrease or morphology
changes were observed, and the viability of parasites was
also well preserved during processing. P. vivax blood
samples filtered by NWF filter were successfully used in
short-term in vitro cultivation. It is also suitable for purify-
ing P. berghei-infected mouse blood and P. falciparum-
infected human blood. A new prototype NWF filter was
successfully developed, and the NWF filter filtration
method is simple, fast and robust, and ideal for purifica-
tion of malaria-infected blood.
Additional material
Additional file 1: The efficacy comparison results of NWF filter
filtration and CF11 column methods for purifying Plasmodium
vivax-infected blood. The WBC, RBC and parasite density results of
Plasmodium vivax-infected blood samples before and post treatment by
NWF filter filtration and CF11 column methods.
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